Ethnic disparities in adherence to breast cancer survivorship surveillance care

Cancer

Volumn 120, Issue 6, 2014, Pages 894-900

  Advani, Pragati S ^a   Ying, Jun ^b   Theriault, Richard ^b   Melhem Bertrand, Amal ^b   Moulder, Stacy ^b   Bedrosian, Isabelle ^b   Tereffe, Welela ^b   Black, Shon ^b   Pini, Tunghi May ^b   Brewster, Abenaa M ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

breast cancer; ethnicity; health care disparities; patient adherence; surveillance; survivorship

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER STAGING; CANCER SURVIVAL; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD; MIDDLE AGED; NEGRO; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES;

BREAST CANCER; ETHNICITY; HEALTH CARE DISPARITIES; PATIENT ADHERENCE; SURVEILLANCE; SURVIVORSHIP;

AGED; BREAST NEOPLASMS; DELIVERY OF HEALTH CARE; EARLY DETECTION OF CANCER; ETHNIC GROUPS; FEMALE; GUIDELINE ADHERENCE; HEALTHCARE DISPARITIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SURVIVAL; SURVIVAL RATE; TEXAS; TREATMENT OUTCOME;

EID: 84896708026     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28490     Document Type: Article

References (48)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
2. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute. http://seer.cancer. gov/csr/1975-2010/. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
3. American Cancer Society. Cancer Facts & Figures 2013. Atlanta, GA: American Cancer Society; 2013.
4. Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon, SW,. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012; 134: 459-478.
5. Khatcheressian JL, Hurley P, Bantug E, et al. American Society of Clinical Oncology. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31: 961-965.
6. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer, Version 3.2013. National Comprehensive Cancer Network. http://www.nccn.com. Accessed May 30, 2013.
7. Keating NL, Landrum MB, Guadagnoli E, Winer, EP, Ayanian JZ,. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006; 24: 85-94. (Pubitemid 46630498)
8. Doubeni CA, Field TS, Ulcickas Yood M, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006; 106: 2482-2488. (Pubitemid 43787674)
9. Field TS, Doubeni C, Fox MP, et al. Underutilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2007; 23: 158-163.
10. Carcaise-Edinboro P, Bradley CJ, Dahman B,. Surveillance mammography for Medicaid/Medicare breast cancer patients. J Cancer Surviv. 2010; 4: 59-66.
11. Sabatino SA, Thompson TD, Richardson LC, Miller J,. Health insurance and other factors associated with mammography surveillance among breast cancer survivors. Med Care. 2012; 50: 270-276.
12. Breslau ES, Jeffery DD, Davis WW, Moser RP, McNeel TS, Hawley S,. Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California Health Interview Survey. J Cancer Surviv. 2010; 4: 1-14.
13. Shelby RA, Scipio CD, Somers TJ, Soo MS, Weinfurt KP, Keefe FJ,. Prospective study of factors predicting adherence to surveillance mammography in women treated for breast cancer. J Clin Oncol. 2012; 30: 813-819.
14. Menashe I, Anderson WF, Jatoi I, Rosenberg PS,. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst. 2009; 101: 993-1000.
15. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott-Raven; 1997.
16. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
17. Litton JK, Gonzalez-Angulo AM, Warneke CL, et al. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol. 2008; 26: 4072-4077.
18. Houston, Sugar Land, Baytown Metro Area. http://www.usa.com/houston- sugar-land-baytown-tx-area.htm. Based on US 2010 data. Accessed 2013.
19. Janz NK, Hawley ST, Mujahid MS, et al. Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer. Cancer. 2011; 117: 1827-1836.
20. Chatman MC, Green RD,. Addressing the unique psychosocial barriers to breast cancer treatment experienced by African-American women through integrative navigation. J Natl Black Nurs Assoc. 2011; 22: 20-28.
21. Rust C, Davis C,. Health literacy and medication adherence in underserved African-American breast cancer survivors: a qualitative study. Soc Work Health Care. 2011; 50: 739-761.
22. Ashing-Giwa KT, Lim J,. Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncol Nurs Forum. 2009; 36: 79-88.
23. Darby K, Davis C, Likes W, Bell J,. Exploring the financial impact of breast cancer for African American medically underserved women: a qualitative study. J Health Care Poor Underserved. 2009; 20: 721-728.
24. Payne S, Jarrett N, Jeffs D,. The impact of travel on cancer patients' experiences of treatment: a literature review. Eur J Cancer Care. 2008; 9: 197-203.
25. Crawford MS, Sauerzapf V, Haynes R, Forman D, Jones AP,. Social and geographical factors affecting access to treatment of colorectal cancer: a cancer registry study. BMJ Open. 2012; 2: 1-6.
26. Holmes J, Carpenter WR, Wu Y, et al. Impact of distance to a urologist on early diagnosis of prostate cancer among black and white patients. J Urol. 2012; 187: 883-888.
27. Mao JJ, Bowman MA, Stricker CT, et al. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol. 2009; 27: 933-938.
28. Cheung WY, Aziz N, Noone AM, et al. Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv. 2013; 7: 343-354.
29. Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA,. Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol. 2013; 31: 2322-2336.
30. Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C,. Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer. 2013; 108: 1515-1524.
31. Hershman DL, Kushi LH, Shao T, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010; 28: 4120-4128.
32. Kimman ML, Bloebaum MM, Dirksen CD, Houben RM, Lambin P, Boersma LJ,. Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer. BMC Cancer. 2010; 10: 1-10.
33. Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S,. Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009; 13: 2-8.
34. Beaver K, Tysver-Robinson D, Campbell M, et al. Comparing hospital and telephone follow-up after treatment for breast cancer: randomized equivalence trial. Br Med J. 2009; 338: a3147.
35. Ruiz JM, Steffen P, Smith TB,. Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. Am J Public Health. 2013; 103: e52-e60.
36. Borrell LN, Lancet EA,. Race/ethnicity and all-cause mortality in US adults: revisiting the Hispanic paradox. Am J Public Health. 2012; 102: 836-843.
37. Newman LA, Mason J, Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival. A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast. Cancer. 2002; 94: 2844-2854. (Pubitemid 34547682)
38. Gerend MA, Pai M,. Social determinants of black-white disparities in breast cancer mortality: a review. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2913-2923.
39. Tannenbaum SL, Koru-Sengul T, Miao F,. Disparities in survival after female breast cancer diagnosis: a population-based study. Cancer Causes Control. 2013; 24: 1705-1715.
40. Ashing-Giwa KT, Padilla G, Tejero J, et al. Understanding the breast cancer experience of women: a qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology. 2004; 13: 408-428. (Pubitemid 38832606)
41. Lim JW, Gonzalez P, Wang-Letzkus MF, Ashing-Giwa KT,. Understanding the cultural health belief model influencing health behaviors and health-related quality of life between Latina and Asian-American breast cancer survivors. Supportive Care Cancer. 2009; 17: 1137-1147.
42. Grunfeld EA, Hunter MS, Sikka P, Mittala S,. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns. 2005; 59: 97-102. (Pubitemid 41399883)
43. Doggrell SA,. Adherence to oral endocrine treatments in women with breast cancer: can it be improved? Breast Cancer Res Treat. 2011; 129: 299-308.
44. Ruddy K, Mayer E, Partridge A,. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009; 59: 56-66.
45. Owusu C, Buist DS, Field TS, et al. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol. 2008; 26: 549-555. (Pubitemid 351264347)
46. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D,. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005; 294: 1765-1772. (Pubitemid 41434622)
47. Edelman MJ, Meyers FJ, Siegel D,. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med. 1997; 12: 318-331. (Pubitemid 27212779)
48. Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999; 17: 1080-1082. (Pubitemid 29109342)